Conference Coverage

Sarilumab shown safe, effective for RA in phase III trial


 

AT THE EULAR CONGRESS 2014

The trial was sponsored by Sanofi and Regeneron, the companies developing the drug. Dr. Genovese said that he has been a consultant to and received research support from Sanofi. Several coauthors are employees of Sanofi or Regeneron.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

VIDEO: Goserelin helps dodge ovarian failure in HR-negative breast cancer
MDedge Family Medicine
Naloxegol cut opioid-associated constipation without impairing pain relief
MDedge Family Medicine
New definition of clinically meaningful CKD progression
MDedge Family Medicine
Proposed PMR guidelines aim to standardize therapy
MDedge Family Medicine
Biosimilars match infliximab, etanercept for RA treatment
MDedge Family Medicine
VIDEO: ACR, EULAR collaborate on first polymyalgia rheumatica treatment guidelines
MDedge Family Medicine
VIDEO: Erectile dysfunction may often occur in men with gout
MDedge Family Medicine
VIDEO: Micro RNA biomarkers hint at potential for predicting OA
MDedge Family Medicine
Treat to target shows durable improvements in psoriatic arthritis
MDedge Family Medicine
Different triggers found for knee and hand OA
MDedge Family Medicine